SB-525334

SynDRA canonical compound SYN1950474 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	TGFBR1
Mechanism of action	TGF beta receptor inhibitor

All known targets

TGFBR1

Mechanisms of action (all sources)

TGF beta receptor inhibitor

Cross-references

Synonyms

SB 525334
SB525334
6-(2-(tert-Butyl)-5-(6-methylpyridin-2-yl)-1H-imidazol-4-yl)quinoxaline
6-[2-TERT-BUTYL-5-(6-METHYL-PYRIDIN-2-YL)-1H-IMIDAZOL-4-YL]-QUINOXALINE
CHEMBL401570
6-[2-(1,1-DiMethylethyl)-5-(6-Methyl-2-pyridinyl)-1H-iMidazol-4-yl]quinoxaline
C21H21N5
6-[2-tert-butyl-5-(6-methylpyridin-2-yl)-1H-imidazol-4-yl]quinoxaline
6-(2-tert-butyl-5-(6-methylpyridin-2-yl)-1H-imidazol-4-yl)quinoxaline
MLS006011134
SCHEMBL373474
QCR-68
SCHEMBL10000768
CTK4H5088
CHEBI:91391
AOB5969

Look up SB-525334 in the interactive SynDRA portal →